This retrospective quality control study aimed at comparing resolution in patients treated with intravitreal ocriplasmin (IVO) using two injection techniques, classical injection procedure (unguided) and targeted injection using a surgical microscope with a 30-gauge 1-inch needle (guided) for the treatment of focal VMT without macular hole. The two groups presented a statistically significant difference in terms of resolution of VMT within the first month following treatment: 1/7 for the unguided group versus 6/7 for the guided group (p = 0.0291). The majority of the guided group presented an earlier resolution than the single resolved case in the unguided group. The results of this preliminary study indicate that the injection of ocriplasm...
Background: To evaluate the functional recovery of patients with symptomatic vitreomacular traction ...
PURPOSE: To evaluate the anatomical and functional outcomes with ocriplasmin in patients with vitreo...
PURPOSE: To evaluate baseline features and morphologic changes of vitreoretinal adhesion and outer ...
This retrospective quality control study aimed at comparing resolution in patients treated with intr...
To evaluate the real world clinical outcomes of intravitreal ocriplasmin in patients with vitreomacu...
AbstractPurpose: To evaluate success with intravitreal injection of ocriplasmin in releasing symptom...
Objective To evaluate the success of an intravitreal injection of ocriplasmin to release symptomatic...
Purpose: To compare the functional and morphologic outcome of patients with vitreomacular traction (...
<p>The VMT resolution rates at 4, 12 and 24 weeks following a single intravitreal injection of ocrip...
PURPOSE: To evaluate the real world clinical outcomes of intravitreal ocriplasmin in patients with v...
Purpose The evaluation of the safety and preliminary efficacy of 125 \u3bcg ocriplasmin intravitreal...
Purpose: To report the clinical course of our first 7 consecutive patients treated with intravitreal...
BACKGROUND AND OBJECTIVE: To determine early evolution of the vitreomacular interface and clinical e...
PURPOSE: To evaluate the efficacy of a single intravitreal injection of ocriplasmin 125 μg across re...
ABSTRACT This study aimed to report the clinical and structural outcomes of intravitreal ocriplasmin...
Background: To evaluate the functional recovery of patients with symptomatic vitreomacular traction ...
PURPOSE: To evaluate the anatomical and functional outcomes with ocriplasmin in patients with vitreo...
PURPOSE: To evaluate baseline features and morphologic changes of vitreoretinal adhesion and outer ...
This retrospective quality control study aimed at comparing resolution in patients treated with intr...
To evaluate the real world clinical outcomes of intravitreal ocriplasmin in patients with vitreomacu...
AbstractPurpose: To evaluate success with intravitreal injection of ocriplasmin in releasing symptom...
Objective To evaluate the success of an intravitreal injection of ocriplasmin to release symptomatic...
Purpose: To compare the functional and morphologic outcome of patients with vitreomacular traction (...
<p>The VMT resolution rates at 4, 12 and 24 weeks following a single intravitreal injection of ocrip...
PURPOSE: To evaluate the real world clinical outcomes of intravitreal ocriplasmin in patients with v...
Purpose The evaluation of the safety and preliminary efficacy of 125 \u3bcg ocriplasmin intravitreal...
Purpose: To report the clinical course of our first 7 consecutive patients treated with intravitreal...
BACKGROUND AND OBJECTIVE: To determine early evolution of the vitreomacular interface and clinical e...
PURPOSE: To evaluate the efficacy of a single intravitreal injection of ocriplasmin 125 μg across re...
ABSTRACT This study aimed to report the clinical and structural outcomes of intravitreal ocriplasmin...
Background: To evaluate the functional recovery of patients with symptomatic vitreomacular traction ...
PURPOSE: To evaluate the anatomical and functional outcomes with ocriplasmin in patients with vitreo...
PURPOSE: To evaluate baseline features and morphologic changes of vitreoretinal adhesion and outer ...